Caveolinopathies are a heterogeneous family of genetic pathologies arising from alterations of the caveolin-3 gene (CAV3), encoding for the isoform specifically constituting muscle caveolae. Here, by reprogramming peripheral blood mononuclear cells, we report the generation of induced pluripotent stem cells (iPSCs) from three patients carrying the ΔYTT deletion, T78K and W101C missense mutations in caveolin-3. iPSCs displayed normal karyotypes and all the features of pluripotent stem cells in terms of morphology, specific marker expression and ability to differentiate in vitro into the three germ layers. These lines thus represent a human cellular model to study the molecular basis of caveolinopathies.
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Resource utility
The established iPSC lines (EURACi001-A, EURACi002-A, EURACi003-A) provide a resource to generate in vitro human cardiomyocytes and myoblast/myotubes in order to understand the molecular and functional mechanisms leading to altered cellular excitability typical of these pathological CAV3 mutations and to evaluate a pharmacological approach to eventually correct such alterations.
Resource details
The term caveolinopathies refers to a group of primary myopathies resulting from alteration of the proteins named caveolin-3, the main constituent of muscle caveolae. These genetic disorders are mainly inherited through an autosomal dominant pattern. The plasma membrane of cardiomyocytes is rich in caveolae and caveolins play multiple roles in the physiology of cardiovascular system (Panneerselvam et al., 2012) . Beyond its role in maintaining the structural integrity of caveolae, caveolin-3 is known to interact with several ion channels in the heart, modifying their functional properties and expression levels (Barbuti et al., 2012; Campostrini et al., 2017) . In order to elucidate in detail the role of CAV3 mutations in skeletal muscle and cardiac diseases, the availability of large quantities of human skeletal muscle and cardiac myocytes is a major requirement. Since iPSC can be differentiated in both these cell types, they provide an unlimited source of human cells otherwise unavailable. We generated iPSCs from three patients carrying different heterozygous mutations in CAV3 genes (Table 1) : one patient who carries a deletion c. , one with c.303 TGG N TGC (W101C) mutation and another patient showing c.233 ACG N AAG (T78K) mutation. At least four iPSC clones were generated from each patient and the iPSC clones (EURACi001-A, EURACi002-A, EURACi003-A) reported in this work were randomly selected and successfully characterized. Specifically, iPSCs were obtained from peripheral blood mononuclear cells (PBMCs) using electroporation of episomal plasmids carrying OCT3/4, SOX2, KLF4, and L-MYC (Meraviglia et al., 2015) . iPSC colonies showed a typical human embryonic-stem cell morphology and were positive for alkaline phosphatase staining ( Supplementary  Fig. 1A ). qRT-PCR analysis revealed that all iPSC lines expressed endogenous pluripotency genes (SOX2, OCT3, NANOG) at higher levels compared to their PBMCs counterpart ( Supplementary Fig. 1B ). Immunofluorescence analysis showed the expression of the pluripotency markers OCT4, SOX2 at nuclear level and SSEA4, TRA-1-60 as surface proteins (Fig. 1A) . Flow cytometry allowed to quantify the percentage of cell positive for SSEA4 (≥ 97.8%) and SOX2 (≥ 79.8) in all the three iPSC lines (Fig. 1B) . The ability of iPSC lines to differentiate into cells of the three germ layers following embryoid body (EB) formation was assessed by qPCR on endodermal (SOX7 and AFP in green), mesodermal (CD31, ACTA2, SCL and CDH5 in red) and ectodermal (KTR14, NCAM1, TH and GABRR2 in blue) genes (Fig. 1C) . Furthermore, direct cardiomyogenic differentiation of all iPSC lines led to the formation of cardiomyocytes, as indicated by immunofluorescence staining of specific cardiac marker (α-Actinin), which displayed a clear sarcomeric pattern (Fig. 1D) . Also, cytogenetic analysis was performed on all iPSC lines, showing a normal karyotype ( Supplementary Fig. 1C ) and genomic DNA sequencing confirmed the presence of all the three mutations in CAV3 gene ( Supplementary Fig. 1D ). Then, STR analysis indicated that iPSCs and their PBMC counterparts yielded a match ≥ 98%, confirming that they are correctly derived from the donor ( Table 2 , data not shown). Finally, PCR results indicated that all the iPSC lines were negative for mycoplasma contamination (Supplementary Fig. 1E ).
Materials and methods

Cell culture and reprogramming
PBMCs obtained from venous peripheral blood were amplified in suspension as previously described (Meraviglia et al., 2015) . 5 × 10 6 PBMCs were reprogrammed by electroporation of 1 μg of each episomal vector (pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL from Addgene) using Neon System (Thermo Fisher Scientific) following the program: 1650 V, 10 ms, 3 pulses. Three days after electroporation, transfected PBMCs were plated on a feeder layer of irradiated mouse embryonic fibroblasts (MEFs) and cultured in iPSC medium containing knockout DMEM, 20% KO-Serum Replacement, 1 mM NEAAs, 1% Penicillin/Streptomycin, 1% L-Glutamine, 0.1 mM β-mercaptoethanol (all from Thermo Fisher Scientific) and 10 ng/ml bFGF (Merck-Millipore) (Meraviglia et al., 2015) . IPSCs maintained on MEFs were expanded by enzymatic dissociation using 1 mg/ml Collagenase IV (Thermo Fisher Scientific). IPSCs adapted to feeder-free condition were cultured in TeSR-E8 medium (Stem Cell Technologies) on Matrigel matrix (Corning) and propagated using PBS-EDTA 0.5 mM.
iPSC differentiation
For differentiation into the three germ layer, iPSCs on MEFs were detached and grown in ultra-low attachment plates for 7 days to form EBs in KO-DMEM (Thermo Fisher Scientific) with 20% FBS Defined (Hyclone), 1 mM NEAAs, 1% Penicillin/Streptomycin, 1% L-Glutamine, 0.1 mM β-mercaptoethanol (all from Thermo Fisher Scientific). EBs were then plated onto 0.1% gelatin-coated dishes for further 10-15 days of differentiation.
Cardiomyogenic differentiation was performed on iPSC cultured in feeder free condition, plating 20,000 cells/cm 2 on 24-well plate coated with Matrigel and using PSC Cardiomyocyte Differentiation Kit (Thermo Fisher Scientific), according to manufacturer's instructions. 
Immunofluorescence staining
Pluripotency markers were detected using Pluripotent Stem Cell 4-Marker Immunocytochemistry Kit (Thermo Fisher Scientific) as indicated by manufacturer's instruction (Table 3) .
After 35 days of differentiation, cardiomyocytes were fixed in PFA 4% for 10 min at room temperature. Blocking of unspecific sites was achieved by incubation with 3% donkey serum in the presence of 0.3% Triton-X100 for 1 h at room temperature. Primary antibodies were incubated overnight at 4°C, while secondary antibodies were incubated 45 min at room temperature (Table 3) . Nuclei were stained with DAPI (Sigma-Aldrich).
Flow cytometry
Flow Cytometry analysis was performed using Multi-Color Flow Cytometry Kit (R&D System) following manufacturer's instruction. Samples were analyzed using FACSAriaII™ flow cytometry (BD Bioscience).
qRT-PCR
Total RNA from PBMCs, iPSCs and EBs was extracted using TRIzol® Reagent and 1 μg of RNA was reverse transcribed using SuperScript VILO cDNA Synthesis Kit following manufacturer's instruction (all from Thermo Fisher Scientific). cDNA was amplified using All-in-One SYBR® Green qPCR Mix (GeneCopoeia) on CFX96 Real-Time PCR Detection System (BioRad). Primers sequences were reported in Table 3 .
Karyotiping
Cytogenetic Q-banding analysis was performed as previously described (Meraviglia et al., 2015) .
Sequencing and STR analysis
Genomic DNA from both iPSCs and corresponding PBMCs was sent to Eurofins Genomics (Germany) for analysis, according to ANSI/ATCC standard ASN-0002 (Table 2 ). In particular, 21 independent loci were investigated by PCR-single-locus-technology (Promega, PowerPlex 21 PCR Kit).
Mycoplasma test
The mycoplasma contamination test was carried out by PCR using primers able to recognize most of the Mycoplasma species (Table 3) .
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